History - Oct 2
Stories, History, and Poetry: Being Human Festival presents a diverse Scottish line-up
Stories, History, and Poetry: Being Human Festival presents a diverse Scottish line-up
Physics - Oct 2
Opinion: Think before shouting at your child: to them, words can be as harmful as physical blows
Opinion: Think before shouting at your child: to them, words can be as harmful as physical blows
Pharmacology - Oct 2
Oxford R21/Matrix-M(TM) malaria vaccine receives WHO recommendation for use paving the way for global roll-out
Oxford R21/Matrix-M(TM) malaria vaccine receives WHO recommendation for use paving the way for global roll-out
Career - Oct 2
Poverty, unemployment, terrorism and global kleptocracy celebrated for real-world impacts
Poverty, unemployment, terrorism and global kleptocracy celebrated for real-world impacts
Environment - Oct 2
Innovative flood resilience project announced as ESRC Celebrating Impact Prize Finalist
Innovative flood resilience project announced as ESRC Celebrating Impact Prize Finalist
wire
« BACK
Health - Pharmacology - 21.10.2021
Health - Pharmacology - 14.10.2021
Health - Pharmacology - 13.10.2021
Health - Pharmacology - 12.10.2021
Health - Pharmacology - 11.10.2021
Health - Pharmacology - 08.10.2021
Health - Pharmacology - 08.10.2021
Health - Pharmacology - 06.10.2021
Health - Pharmacology - 30.09.2021 
Oxford announces expansion of graduate access programme
For the second year in a row, The British Medical Journal have selected a publication co-authored by Oxford researchers for their prestigious UK Research Paper of the Year Award.
Health - Pharmacology - 30.09.2021 
New state-of-the-art centre for immune disease opens
UCL scientists investigating the immune system will work alongside doctors, nurses and patients from the Royal Free Hospital, in a unique partnership that will enable new treatments to be developed more quickly for global health problems, including Covid-19, diabetes and cancer.
Pharmacology - Health - 29.09.2021
Health - Pharmacology - 28.09.2021
Health - Pharmacology - 28.09.2021
Health - Pharmacology - 24.09.2021
Pharmacology - 23.09.2021
Health - Pharmacology - 20.09.2021
Health - Pharmacology - 20.09.2021 
New combination of old drugs improves survival of prostate cancer
Giving the drug abiraterone alongside standard hormone therapy helps men with high-risk prostate cancer that has not spread elsewhere in the body to live longer, according to preliminary results of a UCL-led trial. This result from the STAMPEDE trial, based at the MRC Clinical Trials Unit at UCL and funded by Cancer Research UK and MRC, was presented today at the European Society for Medical Oncology (ESMO) Congress.
Health - Pharmacology - 15.09.2021
Health - Pharmacology - 14.09.2021
Health - Pharmacology - 13.09.2021
Health - Pharmacology - 03.09.2021
Health - Pharmacology - 01.09.2021
Health - Pharmacology - 26.08.2021 
Global COVID-19 surgery study scoops scientific world record
A study led by University of Birmingham experts has been awarded the Guinness World Records title for the world's largest scientific collaboration - involving over 140,000 patients in 116 countries.
Health - Pharmacology - 26.08.2021
Health - Pharmacology - 24.08.2021
Health - Pharmacology - 24.08.2021
Career - Pharmacology - 20.08.2021
Health - Pharmacology - 09.08.2021
Health - Pharmacology - 06.08.2021
Health - Pharmacology - 06.08.2021
Health - Pharmacology - 05.08.2021
Health - Pharmacology - 05.08.2021 
Lab-grown beating heart cells identify potential drug to prevent COVID-19-related heart damage
Cambridge scientists have grown beating heart cells in the lab and shown how they are vulnerable to SARS-CoV-2 infection. In a study published in , they used this system to show that an experimental peptide drug called DX600 can prevent the virus entering the heart cells. Using stem cells, we've managed to create a model which, in many ways, behaves just like a heart does, beating in rhythm.
Health - Pharmacology - 05.08.2021
Health - Pharmacology - 04.08.2021 
Artificial pancreas trialled for outpatients with type 2 diabetes for first time
An artificial pancreas could soon help those people living with type 2 diabetes who also require kidney dialysis.
Pharmacology - Health - 03.08.2021
Health - Pharmacology - 03.08.2021 
Patients who miss multiple GP appointments stay missing from healthcare
Research tracking people across the health service shows that patients who miss multiple GP appointments are not seeking help from Emergency Departments.
Health - Pharmacology - 02.08.2021
Health - Pharmacology - 30.07.2021
Pharmacology - Health - 28.07.2021
Health - Pharmacology - 27.07.2021
Health - Pharmacology - 23.07.2021
Health - Pharmacology - 22.07.2021
Health - Pharmacology - 22.07.2021
Health - Pharmacology - 20.07.2021
Health - Pharmacology - 19.07.2021 
New research studies to help diagnose and treat Long COVID funded by NIHR
Three projects at Oxford have received funding from NIHR to assess breathlessness in Long COVID patients, investigate the impact of Long COVID on families, and examine the role of vaccines in Long COVID.
Pharmacology - Health - 19.07.2021
Health - Pharmacology - 16.07.2021
Health - Pharmacology - 15.07.2021
Health - Pharmacology - 13.07.2021
Health - Pharmacology - 09.07.2021
Pharmacology
Results 201 - 250 of 658.
Type 2 diabetes health checks down by 7.4 million due to UK’s covid restrictions in 2020
Manchester-based researchers estimate that between March and December 2020, 7.4 million fewer NICE recommended health care checks took place in UK general practices in people with type 2 diabetes, when compared to 10-year historical trends.
Manchester-based researchers estimate that between March and December 2020, 7.4 million fewer NICE recommended health care checks took place in UK general practices in people with type 2 diabetes, when compared to 10-year historical trends.
New guidelines to improve pregnancy trials will pave way for novel therapies for women and babies
A new grading system to monitor complications during clinical trials involving pregnant women, which will significantly improve their safety, has been co-developed by UCL researchers and an internati
A new grading system to monitor complications during clinical trials involving pregnant women, which will significantly improve their safety, has been co-developed by UCL researchers and an internati
Opinion: Why England should pursue a ’vaccine plus’ strategy
Instead of relying on vaccines alone, countries such as France and Germany are using extra measures to keep cases and deaths low - England should follow their example, argues Professor Christina Pagel (UCL Mathematics) in a co-authored piece with Professor Martin McKee.
Instead of relying on vaccines alone, countries such as France and Germany are using extra measures to keep cases and deaths low - England should follow their example, argues Professor Christina Pagel (UCL Mathematics) in a co-authored piece with Professor Martin McKee.
Heroin overdose deaths often happen shortly after leaving hospital
Drug-related deaths are four times more likely to occur in the two days after hospital discharge than at any other time among users of opioids such as heroin, according to research led by UCL, Public Health England (PHE)* and King's College London. The peer-reviewed study, published today in PLOS Medicine, looked at data from 13,609 adults in England, who were aged between 18 and 64 and died after using non-prescribed opioids between 2010 and 2019.
Drug-related deaths are four times more likely to occur in the two days after hospital discharge than at any other time among users of opioids such as heroin, according to research led by UCL, Public Health England (PHE)* and King's College London. The peer-reviewed study, published today in PLOS Medicine, looked at data from 13,609 adults in England, who were aged between 18 and 64 and died after using non-prescribed opioids between 2010 and 2019.
For the second year in a row, The British Medical Journal have selected a publication co-authored by Oxford researchers for their prestigious UK Research Paper of the Year Award.
UCL scientists investigating the immune system will work alongside doctors, nurses and patients from the Royal Free Hospital, in a unique partnership that will enable new treatments to be developed more quickly for global health problems, including Covid-19, diabetes and cancer.
Opinion: Long-term antidepressant use is effective, but many people can come off them safely
Many people on depressants continue taking them for fear of having a relapse but new research could help doctors and patients make more informed decisions, say Dr Gemma Lewis and Professor Glyn Lewis (both UCL Psychiatry). The number of prescriptions written for antidepressants in wealthy countries has doubled in the past 20 years.
Many people on depressants continue taking them for fear of having a relapse but new research could help doctors and patients make more informed decisions, say Dr Gemma Lewis and Professor Glyn Lewis (both UCL Psychiatry). The number of prescriptions written for antidepressants in wealthy countries has doubled in the past 20 years.
Moonshot initiative to develop affordable COVID-19 antivirals gets funding boost
The COVID Moonshot, a non-profit, open-science consortium of scientists from around the world dedicated to the discovery of globally affordable and easily-manufactured antiviral drugs against COVID-1
The COVID Moonshot, a non-profit, open-science consortium of scientists from around the world dedicated to the discovery of globally affordable and easily-manufactured antiviral drugs against COVID-1
Early trial of multivariant COVID-19 vaccine booster begins in Manchester
A phase one trial of a multivariant COVID-19 Vaccine has been launched by US pharmaceutical company Gritstone in collaboration with The University of Manchester and Manchester University NHS Foundation Trust.
A phase one trial of a multivariant COVID-19 Vaccine has been launched by US pharmaceutical company Gritstone in collaboration with The University of Manchester and Manchester University NHS Foundation Trust.
Giving the drug abiraterone alongside standard hormone therapy helps men with high-risk prostate cancer that has not spread elsewhere in the body to live longer, according to preliminary results of a UCL-led trial. This result from the STAMPEDE trial, based at the MRC Clinical Trials Unit at UCL and funded by Cancer Research UK and MRC, was presented today at the European Society for Medical Oncology (ESMO) Congress.
New study will use artificial intelligence to improve treatments for people with multiple long-term conditions
The NIHR has awarded £2.5 million for new research led by the University of Birmingham that will use artificial intelligence (AI) to produce computer programmes and tools that will help doctors improve the choice of drugs in patients with clusters of multiple long-term conditions.
The NIHR has awarded £2.5 million for new research led by the University of Birmingham that will use artificial intelligence (AI) to produce computer programmes and tools that will help doctors improve the choice of drugs in patients with clusters of multiple long-term conditions.
Dog vaccination essential for preventing rabies spread to humans and animals
A coordinated and sustained programme of dog vaccination against rabies, is effective in preventing transmission of the deadly virus to humans and among animals, and remains key to rabies elimination. New research, led by the University of Glasgow in collaboration with Ifakara Health Institute and Imperial College London, published today in Applied Ecology, found that rabies incidence in both humans and domestic dogs decreased during a period of sustained dog vaccination in southeast Tanzania, despite incidences of ongoing wildlife rabies infections.
A coordinated and sustained programme of dog vaccination against rabies, is effective in preventing transmission of the deadly virus to humans and among animals, and remains key to rabies elimination. New research, led by the University of Glasgow in collaboration with Ifakara Health Institute and Imperial College London, published today in Applied Ecology, found that rabies incidence in both humans and domestic dogs decreased during a period of sustained dog vaccination in southeast Tanzania, despite incidences of ongoing wildlife rabies infections.
A study led by University of Birmingham experts has been awarded the Guinness World Records title for the world's largest scientific collaboration - involving over 140,000 patients in 116 countries.
Woman who has lived with 30 year cough receives world-first dose of potential new treatment
A 70-year-old woman, forced to live with cough since her 40s, is 'excited' to be the first person in the world to receive a potential new cough treatment at the NIHR Manchester Clinical Research Facility (CRF) .
A 70-year-old woman, forced to live with cough since her 40s, is 'excited' to be the first person in the world to receive a potential new cough treatment at the NIHR Manchester Clinical Research Facility (CRF) .
New study to test third COVID-19 vaccine for people with weakened immune systems
A new clinical trial led by the Universities of Birmingham and Glasgow has launched in the UK to determine whether a third dose of vaccine will improve the immune response for people who have weakened immune systems. The study, OCTAVE DUO, will offer people who are immunosuppressed or immunocompromised a Pfizer, Moderna or Novavax vaccine to determine whether this will give a stronger immune response than two doses.
A new clinical trial led by the Universities of Birmingham and Glasgow has launched in the UK to determine whether a third dose of vaccine will improve the immune response for people who have weakened immune systems. The study, OCTAVE DUO, will offer people who are immunosuppressed or immunocompromised a Pfizer, Moderna or Novavax vaccine to determine whether this will give a stronger immune response than two doses.
Low or undetectable immune response to double COVID-19 vaccination in patients with impaired immune systems
Study shows low or undetectable immune response to double COVID-19 vaccination in patients with impaired immune systems The first data from the ongoing OCTAVE study show that a significant proportion of clinically at-risk patients with certain immunocompromised or immunosuppressed conditions mount a low or undetectable immune response after two doses of the same COVID-19 vaccine.
Study shows low or undetectable immune response to double COVID-19 vaccination in patients with impaired immune systems The first data from the ongoing OCTAVE study show that a significant proportion of clinically at-risk patients with certain immunocompromised or immunosuppressed conditions mount a low or undetectable immune response after two doses of the same COVID-19 vaccine.
Interview: Prof Francois Balloux - ’The pandemic has created a market for gloom and doom’
Francois Balloux (UCL Genetics Institute) discusses the risk of new variants, psychosomatic long Covid and when he expects the crisis to end.
Francois Balloux (UCL Genetics Institute) discusses the risk of new variants, psychosomatic long Covid and when he expects the crisis to end.
Licensed drug could reduce SARS-CoV-2 infection by up to 70 per cent, reveals study
A licensed drug normally used to treat abnormal levels of fatty substances in the blood could reduce infection caused by the SARS-CoV-2 virus by up to 70 per cent, reveals a study in the laboratory by an international collaboration of researchers. The research team, led by the University of Birmingham and Keele University in the UK and the San Raffaele Scientific Institute in Italy, has demonstrated that fenofibrate and its active form (fenofibric acid) can significantly reduce SARS-COV-2 infection in human cells in the laboratory.
A licensed drug normally used to treat abnormal levels of fatty substances in the blood could reduce infection caused by the SARS-CoV-2 virus by up to 70 per cent, reveals a study in the laboratory by an international collaboration of researchers. The research team, led by the University of Birmingham and Keele University in the UK and the San Raffaele Scientific Institute in Italy, has demonstrated that fenofibrate and its active form (fenofibric acid) can significantly reduce SARS-COV-2 infection in human cells in the laboratory.
Medicines Discovery Catapult relaunches Wolfson Radiochemistry facility in Manchester
Medicines Discovery Catapult (MDC) today announces the relaunch of radiochemistry at the Wolfson Molecular Imaging Centre (WMIC) in Manchester.
Medicines Discovery Catapult (MDC) today announces the relaunch of radiochemistry at the Wolfson Molecular Imaging Centre (WMIC) in Manchester.
Cambridge scientists have grown beating heart cells in the lab and shown how they are vulnerable to SARS-CoV-2 infection. In a study published in , they used this system to show that an experimental peptide drug called DX600 can prevent the virus entering the heart cells. Using stem cells, we've managed to create a model which, in many ways, behaves just like a heart does, beating in rhythm.
RECOVERY-RS trial finds continuous positive airway pressure (CPAP) reduces need for invasive ventilation in hospitalised COVID-19 patients
Landmark UK trial compared three commonly used respiratory interventions to establish which works best for COVID-19 patients with acute respiratory failure.
Landmark UK trial compared three commonly used respiratory interventions to establish which works best for COVID-19 patients with acute respiratory failure.
An artificial pancreas could soon help those people living with type 2 diabetes who also require kidney dialysis.
World-first UK trial to assess whether cannabis-based drug could extend life for thousands with aggressive brain tumours
The University of Birmingham will co-ordinate a major UK trial to analyse the efficacy of cannabis-based drug Sativex in treating the most aggressive form of brain tumours.
The University of Birmingham will co-ordinate a major UK trial to analyse the efficacy of cannabis-based drug Sativex in treating the most aggressive form of brain tumours.
Research tracking people across the health service shows that patients who miss multiple GP appointments are not seeking help from Emergency Departments.
New data show rise in hospital admissions for unvaccinated pregnant women
The Chief Midwifery Officer for England will urge expectant mums to have their COVID-19 vaccination as soon as possible.
The Chief Midwifery Officer for England will urge expectant mums to have their COVID-19 vaccination as soon as possible.
Expansion of MR and CT imaging at Salford Royal
Three new, state of the art MRI (Magnetic Resonance Imaging) scanners and a new CT (Computed Tomography) scanner have been installed at Salford Royal, part of the Northern Care Alliance NHS Group (NCA).
Three new, state of the art MRI (Magnetic Resonance Imaging) scanners and a new CT (Computed Tomography) scanner have been installed at Salford Royal, part of the Northern Care Alliance NHS Group (NCA).
Opinion: We cannot escape the threat of Covid-19 until we vaccinate the world
G7 countries are guilty of both hoarding Covid-19 vaccines and blocking others from producing them at scale, says Professor Anthony Costello (UCL Institute for Global Health).
G7 countries are guilty of both hoarding Covid-19 vaccines and blocking others from producing them at scale, says Professor Anthony Costello (UCL Institute for Global Health).
UCLH begins clinical trial of Alzheimer’s drug developed at UCL
A clinical trial of a new drug candidate for Alzheimer's disease which has been developed at UCL in partnership with the pharmaceutical company Eisai has begun at UCLH with participants now being screened. Participants in the trial, conducted at the UCLH Leonard Wolfson Experimental Neurology Centre (NIHR UCLH Clinical Research Facility), will have the rare inherited form of Alzheimer's disease.
A clinical trial of a new drug candidate for Alzheimer's disease which has been developed at UCL in partnership with the pharmaceutical company Eisai has begun at UCLH with participants now being screened. Participants in the trial, conducted at the UCLH Leonard Wolfson Experimental Neurology Centre (NIHR UCLH Clinical Research Facility), will have the rare inherited form of Alzheimer's disease.
Vaccine antibody levels start to wane at around 2-3 months
Total antibody levels appear to start declining from as early as six weeks after complete vaccination and can reduce by more than 50% over 10 weeks, according to new data from UCL's Virus Watch study.
Total antibody levels appear to start declining from as early as six weeks after complete vaccination and can reduce by more than 50% over 10 weeks, according to new data from UCL's Virus Watch study.
Study launched to investigate diet treatment for long COVID
Researchers from the University of Glasgow have been awarded £1 million from the National Institute for Health Research (NIHR) to investigate weight loss treatment for long COVID.
Researchers from the University of Glasgow have been awarded £1 million from the National Institute for Health Research (NIHR) to investigate weight loss treatment for long COVID.
Three projects at Oxford have received funding from NIHR to assess breathlessness in Long COVID patients, investigate the impact of Long COVID on families, and examine the role of vaccines in Long COVID.
New Zealand drug agency provides model to help insulate NICE from impacts of post-Brexit trade deals
An investigation by CASP researchers suggests safeguards put in place in New Zealand to protect drug policy offer important lessons for UK trade deals.
An investigation by CASP researchers suggests safeguards put in place in New Zealand to protect drug policy offer important lessons for UK trade deals.
Opinion: If Covid-19 is a seasonal virus, why is it spreading during the summer?
Understanding seasonality can help us to work out when the pandemic is likely to be over, says Professor Francois Balloux (UCL Genetics Institute).
Understanding seasonality can help us to work out when the pandemic is likely to be over, says Professor Francois Balloux (UCL Genetics Institute).
Partnership will create the next generation of researchers to transform global healthcare
The Universities of Birmingham, Leicester and Nottingham have joined forces to launch a partnership that will train the next generation of leading researchers the skills required to transform our understanding and treatment of disease.
The Universities of Birmingham, Leicester and Nottingham have joined forces to launch a partnership that will train the next generation of leading researchers the skills required to transform our understanding and treatment of disease.
Opinion: Boris Johnson gave two reasons for lifting all restrictions. Both are wrong
Allowing mass infections now is a terrible idea, even with so many vaccinated. The NHS will struggle to cope, says Professor Christina Pagel (UCL Mathematics).
Allowing mass infections now is a terrible idea, even with so many vaccinated. The NHS will struggle to cope, says Professor Christina Pagel (UCL Mathematics).
COVID:19: Scientists condemn government’s ’dangerous & unethical COVID-19 experiment’
University of Birmingham scientists are among more than 100 experts who have signed a letter published in The Lancet accusing the UK government of conducting a 'dangerous and unethical experiment' and urging it to reconsider its plans to abandon all COVID-19 restrictions.
University of Birmingham scientists are among more than 100 experts who have signed a letter published in The Lancet accusing the UK government of conducting a 'dangerous and unethical experiment' and urging it to reconsider its plans to abandon all COVID-19 restrictions.
History - Oct 2
Stories, History, and Poetry: Being Human Festival presents a diverse Scottish line-up
Stories, History, and Poetry: Being Human Festival presents a diverse Scottish line-up
Physics - Oct 2
Opinion: Think before shouting at your child: to them, words can be as harmful as physical blows
Opinion: Think before shouting at your child: to them, words can be as harmful as physical blows
Pharmacology - Oct 2
Oxford R21/Matrix-M(TM) malaria vaccine receives WHO recommendation for use paving the way for global roll-out
Oxford R21/Matrix-M(TM) malaria vaccine receives WHO recommendation for use paving the way for global roll-out
Career - Oct 2
Poverty, unemployment, terrorism and global kleptocracy celebrated for real-world impacts
Poverty, unemployment, terrorism and global kleptocracy celebrated for real-world impacts
Environment - Oct 2
Innovative flood resilience project announced as ESRC Celebrating Impact Prize Finalist
Innovative flood resilience project announced as ESRC Celebrating Impact Prize Finalist